Marker Therapeutics Inc (MRKR)
NASDAQ:MRKR
Holding MRKR?
Track your performance easily

Marker Therapeutics (MRKR) Financial Statements

490 Followers

Marker Therapeutics Financial Overview

Marker Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.16; its P/E ratio is -2.39; Marker Therapeutics is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is $-0.39. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Jun 23Mar 23
Income Statement-
Total Revenue$ 1.17M$ 1.24M$ 1.06M$ 762.66K-
Gross Profit$ 1.17M$ 1.24M$ 1.06M$ 762.66K-
EBIT$ -2.19M$ -2.39M$ -2.94M$ -4.10M$ -4.97M
EBITDA$ -2.19M$ -2.39M$ -2.94M$ -5.07M$ -4.00M
Net Income Common Stockholders$ -2.19M$ -2.39M$ -2.80M$ 9.13M$ -4.97M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 7.80M$ 11.30M$ 15.10M$ 18.10M$ 6.40M
Total Assets$ 11.68M$ 14.09M$ 17.13M$ 21.96M$ 27.91M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 7.49M
Net Debt$ -7.80M$ -11.30M$ -15.10M$ -18.10M$ 1.09M
Total Liabilities$ 1.97M$ 2.30M$ 3.07M$ 2.92M$ 12.03M
Stockholders Equity$ 9.70M$ 11.79M$ 14.05M$ 19.03M$ 15.91M
Cash Flow-
Free Cash Flow$ -3.57M$ -3.84M$ -2.37M$ -7.06M$ -5.89M
Operating Cash Flow$ -3.57M$ -3.84M$ -2.37M$ -7.06M$ -5.89M
Investing Cash Flow---$ 18.78M$ -112.61K
Financing Cash Flow$ 44.61K$ 49.10K$ 5.13K$ 736.00$ 619.97K
Currency in USD

Marker Therapeutics Earnings and Revenue History

Marker Therapeutics Debt to Assets

Marker Therapeutics Cash Flow

Marker Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis